Demand for mycotoxin testing will increase through 2036, with analytics services third party independent testing at 40.0% of the engagement type segment in 2026. The market is expected to reach USD 1.81 billion in 2026 and USD 3.43 billion by 2036, creating an absolute dollar opportunity of USD 1.62 billion.